Article

Diagnostic Performance of ELISA and RIA in AChR Antibody Testing for Myasthenia Gravis: A Real- World Cohort Study

2026-05-26

Abstract excerpt

<title>Abstract</title> <p>Background: AChR antibody testing is central to the diagnosis of myasthenia gravis (MG). While radioimmunoassays (RIA) have long been considered the reference method, enzyme-linked immunosorbent assays (ELISA) are increasingly used in routine practice. Differences in analytical characteristics may influence diagnostic performance in real-world settings. <h4>Methods:</h4> We retrospecti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 57516116-8f2c-5f7a-87f4-81e59da3198c
DOI: 10.21203/rs.3.rs-9538994/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Diagnostic Performance of ELISA and RIA in AChR Antibody Testing for Myasthenia Gravis: A Real- World Cohort StudyDOI 10.21203/rs.3.rs-9538994/v1Read

Clinical aspects and serodiagnosis of myasthenia gravis in Algerian patients: a prospective study on a small group of patientsSemantic proximity Read

Distribution and Temporal Changes of Autoantibody-Mediated Pathogenic Mechanisms Among Acetylcholine Receptor-Positive Myasthenia Gravis PatientsSemantic proximity Read

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.Semantic proximity Read

Clinical utility of autoantibodies in the diagnosis and management of Myasthenia gravisSemantic proximity Read

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.Semantic proximity Read

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read

The epidemiology of myasthenia gravis.Semantic proximity Read

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read

Heterogeneity of acetylcholine receptor autoantibody-mediated complement activity in patients with myasthenia gravisSemantic proximity Read

Clinical characteristics and outcome of treatment-refractory myasthenia gravis -a retrospective studySemantic proximity Read

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and OutcomesSemantic proximity Read